The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
Upstream of the mammalian target of rapamycin: do all roads pass through mTOR?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 18×
“However, although AMPK activation is one mechanism by which mTOR could be suppressed by stress, several other mechanisms have been proposed to explain how mTOR is regulated during shorter time periods, when ATP levels may still be in the normal range.”
BackgroundInfluentialUpstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
Self-citationTSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Self-citationKim, D.-H., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2002) · Cell · doi:10.1016/s0092-8674(02)00808-5 · Cited by 2,986
Bodine, S. C., Stitt, T. N., Gonzalez, M., Kline, W. O., Stover, G. L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J. C., Glass, D. J., et al. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1014 · Cited by 2,752
Sarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Rüegg, M. A., Hall, A., & Hall, M. N. (2004) · Nature Cell Biology · doi:10.1038/ncb1183 · Cited by 2,114
A mammalian protein targeted by G1-arresting rapamycin–receptor complex
Brown, E. J., Albers, M. W., Bum Shin, T., ichikawa, K., Keith, C. T., Lane, W. S., & Schreiber, S. L. (1994) · Nature · doi:10.1038/369756a0 · Cited by 2,053
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
Inoki, K., Li, Y., Xu, T., & Guan, K.-L. (2003) · Genes & Development · doi:10.1101/gad.1110003 · Cited by 1,911
Self-citationLoewith, R., Jacinto, E., Wullschleger, S., Lorberg, A., Crespo, J. L., Bonenfant, D., Oppliger, W., Jenoe, P., & Hall, M. N. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00636-6 · Cited by 1,886
Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action
Hara, K., Maruki, Y., Long, X., Yoshino, K.-I., Oshiro, N., Hidayat, S., Tokunaga, C., Avruch, J., & Yonezawa, K. (2002) · Cell · doi:10.1016/s0092-8674(02)00833-4 · Cited by 1,810
Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J., et al. (2004) · Nature · doi:10.1038/nature02866 · Cited by 1,677
LKB1 is the upstream kinase in the AMP-activated protein kinase cascade
Woods, A., Johnstone, S. R., Dickerson, K., Leiper, F. C., Fryer, L. G. D., Neumann, D., Schlattner, U., Wallimann, T., Carlson, M., & Carling, D. (2003) · Current Biology · doi:10.1016/j.cub.2003.10.031 · Cited by 1,650
AMP-activated protein kinase induces a p53-dependent metabolic checkpoint
Jones, R. G., Plas, D. R., Kubek, S., Buzzai, M., Mu, J., Xu, Y., Birnbaum, M. J., & Thompson, C. B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.027 · Cited by 1,619
Growing roles for the mTOR pathway
Sarbassov, D. D., Ali, S. M., & Sabatini, D. M. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.09.009 · Cited by 1,560
Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P., & Snyder, S. H. (1994) · Cell · doi:10.1016/0092-8674(94)90570-3 · Cited by 1,509
Brugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W., & Kaelin, W. G. (2004) · Genes & Development · doi:10.1101/gad.1256804 · Cited by 1,384 · cited 3×
“RTP801 is transcriptionally induced by HIF-1 under conditions of hypoxia (Shoshani et al., 2002) and is required for the effect of hypoxia on mTOR, as RTP801 null MEFs are defective in hypoxia-mediated inhibition of S6K (Brugarolas et al., 2004).”
BackgroundLKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR‐1
Lizcano, J. M., Göransson, O., Toth, R., Deak, M., Morrice, N. A., Boudeau, J., Hawley, S. A., Udd, L., Mäkelä, T. P., Hardie, D. G., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600110 · Cited by 1,381
Hara, K., Yonezawa, K., Weng, Q.-P., Kozlowski, M. T., Belham, C., & Avruch, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14484 · Cited by 1,367
Phosphorylation and Functional Inactivation of TSC2 by Erk
Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P., & Pandolfi, P. P. (2005) · Cell · doi:10.1016/j.cell.2005.02.031 · Cited by 1,268 · cited 3×
“Notably, Erk-driven tumorigenesis in TSC2þ / tumor cells was shown to be blocked by an Erk- nonphosphorylatable TSC2 mutant, but reintroduction of wild-type TSC2 was ineffective in suppressing tumor growth (Ma et al., 2005a).”
BackgroundHolz, M. K., Ballif, B. A., Gygi, S. P., & Blenis, J. (2005) · Cell · doi:10.1016/j.cell.2005.10.024 · Cited by 1,262
Fingar, D. C., & Blenis, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207542 · Cited by 1,247
The coordinate regulation of the p53 and mTOR pathways in cells
Feng, Z., Zhang, H., Levine, A. J., & Jin, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502857102 · Cited by 1,235
Eisen, H. J., Tuzcu, E. M., Dorent, R., Kobashigawa, J., Mancini, D., Valantine-von Kaeppler, H. A., Starling, R. C., Sørensen, K., Hummel, M., Lind, J. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022171 · Cited by 1,198
Hudson, C. C., Liu, M., Chiang, G. G., Otterness, D. M., Loomis, D. C., Kaper, F., Giaccia, A. J., & Abraham, R. T. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7004-7014.2002 · Cited by 1,186
The AMP-activated protein kinase pathway – new players upstream and downstream
Hardie, D. G. (2004) · Journal of Cell Science · doi:10.1242/jcs.01540 · Cited by 1,143
The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins
Harrington, L. S., Findlay, G. M., Gray, A., Tolkacheva, T., Wigfield, S., Rebholz, H., Barnett, J., Leslie, N. R., Cheng, S., Shepherd, P. R., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403069 · Cited by 1,123
Tee, A. R., Manning, B. D., Roux, P. P., Cantley, L. C., & Blenis, J. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00506-2 · Cited by 1,080
The LKB1 tumor suppressor negatively regulates mTOR signaling
Shaw, R. J., Bardeesy, N., Manning, B. D., Lopez, L., Kosmatka, M., DePinho, R. A., & Cantley, L. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.007 · Cited by 1,077
Insulin Activation of Rheb, a Mediator of mTOR/S6K/4E-BP Signaling, Is Inhibited by TSC1 and 2
Garami, A., Zwartkruis, F. J. T., Nobukuni, T., Joaquin, M., Roccio, M., Stocker, H., Kozma, S. C., Hafen, E., Bos, J. L., & Thomas, G. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00220-x · Cited by 1,043
Rheb Binds and Regulates the mTOR Kinase
Long, X., Lin, Y., Ortiz-Vega, S., Yonezawa, K., & Avruch, J. (2005) · Current Biology · doi:10.1016/j.cub.2005.02.053 · Cited by 1,005 · cited 2×
“Some studies suggest that Rheb is integral to nutrient sensing, as overexpressed Rheb has been shown to override nutrient deprivation signals to mTOR (Inoki et al., 2003a), and nutrient deprivation signals may decrease Rheb binding to mTOR (Long et al., 2005b).”
BackgroundDysregulation of the TSC-mTOR pathway in human disease
Inoki, K., Corradetti, M. N., & Guan, K.-L. (2005) · Nature Genetics · doi:10.1038/ng1494 · Cited by 972
Self-citationEnhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR
Neshat, M. S., Mellinghoff, I. K., Tran, C., Stiles, B., Thomas, G., Petersen, R., Frost, P., Gibbons, J. J., Wu, H., & Sawyers, C. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171076798 · Cited by 969
Majumder, P. K., Febbo, P. G., Bikoff, R., Berger, R., Xue, Q., McMahon, L. M., Manola, J., Brugarolas, J., McDonnell, T. J., Golub, T. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1052 · Cited by 964
Mammalian TOR: a homeostatic ATP sensor
Dennis, P. B., Jaeschke, A., Saitoh, M., Fowler, B., Kozma, S. C., & Thomas, G. (2001) · Science · doi:10.1126/science.1063518 · Cited by 962
Kim, D.-H., Sarbassov, D. D., Ali, S. M., Latek, R. R., Guntur, K. V. P., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00114-x · Cited by 961
Akt regulates growth by directly phosphorylating Tsc2
Potter, C. J., Pedraza, L. G., & Xu, T. (2002) · Nature Cell Biology · doi:10.1038/ncb840 · Cited by 959
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy
Wendel, H.-G., Stanchina, E. D., Fridman, J. S., Malina, A., Ray, S., Kogan, S., Cordon-Cardo, C., Pelletier, J., & Lowe, S. W. (2004) · Nature · doi:10.1038/nature02369 · Cited by 951
Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells
Sabers, C. J., Martin, M. M., Brunn, G. J., Williams, J. M., Dumont, F. J., Wiederrecht, G., & Abraham, R. T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.815 · Cited by 887
Bolster, D. R., Crozier, S. J., Kimball, S. R., & Jefferson, L. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200171200 · Cited by 851 · cited 1×
“…activation of AMPK by the ribonucleoside AMP analog AICAR caused a dramatic reduction of S6K and 4EBP1 activity; and culturing cells in low glucose or treating cells with 2- DG had the same effect of reducing mTOR activation (Bolster et al., 2002; Krause et al., 2002; Kimura et al., 2003).”
BackgroundPhosphorylation of the Translational Repressor PHAS-I by the Mammalian Target of Rapamycin
Brunn, G. J., Hudson, C. C., Sekulić, A., Williams, J. M., Hosoi, H., Houghton, P. J., Lawrence, J. C., & Abraham, R. T. (1997) · Science · doi:10.1126/science.277.5322.99 · Cited by 846
Shah, O. J., Wang, Z., & Hunter, T. (2004) · Current Biology · doi:10.1016/j.cub.2004.08.026 · Cited by 798
PTEN: One Gene, Many Syndromes
Eng, C. (2003) · Human Mutation · doi:10.1002/humu.10257 · Cited by 787
Nobukuni, T., Joaquin, M., Roccio, M., Dann, S. G., Kim, S. Y., Gulati, P., Byfield, M. P., Backer, J. M., Natt, F., Bos, J. L., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506925102 · Cited by 757
Roux, P. P., Ballif, B. A., Anjum, R., Gygi, S. P., & Blenis, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405659101 · Cited by 750
Boonstra, J., & Post, J. A. (2004) · Gene · doi:10.1016/j.gene.2004.04.032 · Cited by 737
Drosophila S6 Kinase: A Regulator of Cell Size
Montagne, J., Stewart, M. J., Stocker, H., Hafen, E., Kozma, S. C., & Thomas, G. (1999) · Science · doi:10.1126/science.285.5436.2126 · Cited by 717
Control of p70 S6 kinase by kinase activity of FRAP in vivo
Brown, E. J., Beal, P. A., Keith, C. T., Chen, J., Bum Shin, T., & Schreiber, S. L. (1995) · Nature · doi:10.1038/377441a0 · Cited by 705
Tsc tumour suppressor proteins antagonize amino-acid–TOR signalling
Gao, X., Zhang, Y., Arrazola, P., Hino, O., Kobayashi, T., Yeung, R. S., Ru, B., & Pan, D. (2002) · Nature Cell Biology · doi:10.1038/ncb847 · Cited by 672
Rheb promotes cell growth as a component of the insulin/TOR signalling network
Saucedo, L. J., Gao, X., Chiarelli, D. A., Li, L., Pan, D., & Edgar, B. A. (2003) · Nature Cell Biology · doi:10.1038/ncb996 · Cited by 658
Regulation of cellular growth by the Drosophila target of rapamycin dTOR
Zhang, H., Stallock, J. P., Ng, J. C., Reinhard, C., & Neufeld, T. P. (2000) · Genes & Development · doi:10.1101/gad.835000 · Cited by 624
mTOR Is Essential for Growth and Proliferation in Early Mouse Embryos and Embryonic Stem Cells
Murakami, M., Ichisaka, T., Maeda, M., Oshiro, N., Hara, K., Edenhofer, F., Kiyama, H., Yonezawa, K., & Yamanaka, S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6710-6718.2004 · Cited by 624
Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family.
Jefferies, H. B., Reinhard, C., Kozma, S. C., & Thomas, G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4441 · Cited by 623
Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer
Thomas, G. V., Tran, C., Mellinghoff, I. K., Welsbie, D. S., Chan, E., Fueger, B., Czernin, J., & Sawyers, C. L. (2006) · Nature Medicine · doi:10.1038/nm1337 · Cited by 604
The NF1 tumor suppressor critically regulates TSC2 and mTOR
Johannessen, C. M., Reczek, E. E., James, M. F., Brems, H., Legius, E., & Cichowski, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503224102 · Cited by 601
An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/−mice
Podsypanina, K., Lee, R. T., Politis, C., Hennessy, I., Crane, A., Puc, J., Neshat, M., Wang, H., Yang, L., Gibbons, J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171060098 · Cited by 569
Corradetti, M. N., Inoki, K., Bardeesy, N., DePinho, R. A., & Guan, K.-L. (2004) · Genes & Development · doi:10.1101/gad.1199104 · Cited by 560
Self-citationIdentification of a Novel Hypoxia-Inducible Factor 1-Responsive Gene, RTP801 , Involved in Apoptosis
Shoshani, T., Faerman, A., Mett, I., Zelin, E., Tenne, T., Gorodin, S., Moshel, Y., Elbaz, S., Budanov, A., Chajut, A., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2283-2293.2002 · Cited by 546
The Drosophila Tuberous Sclerosis Complex Gene Homologs Restrict Cell Growth and Cell Proliferation
Tapon, N., Ito, N., Dickson, B. J., Treisman, J. E., & Hariharan, I. K. (2001) · Cell · doi:10.1016/s0092-8674(01)00332-4 · Cited by 542
Rheb is an essential regulator of S6K in controlling cell growth in Drosophila
Stocker, H., Radimerski, T., Schindelholz, B., Wittwer, F., Belawat, P., Daram, P., Breuer, S., Thomas, G., & Hafen, E. (2003) · Nature Cell Biology · doi:10.1038/ncb995 · Cited by 530
TSC2 regulates VEGF through mTOR-dependent and -independent pathways
Brugarolas, J. B., Vazquez, F., Reddy, A., Sellers, W. R., & Kaelin, W. G. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00187-9 · Cited by 528
hVps34 Is a Nutrient-regulated Lipid Kinase Required for Activation of p70 S6 Kinase
Byfield, M. P., Murray, J. T., & Backer, J. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507201200 · Cited by 527
Potter, C. J., Huang, H., & Xu, T. (2001) · Cell · doi:10.1016/s0092-8674(01)00333-6 · Cited by 521
Akt/Protein Kinase B Promotes Organ Growth in Transgenic Mice
Shioi, T., McMullen, J. R., Kang, P. M., Douglas, P. S., Obata, T., Franke, T. F., Cantley, L. C., & Izumo, S. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2799-2809.2002 · Cited by 506
The expanding TOR signaling network
Martin, D. E., & Hall, M. N. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.02.008 · Cited by 494
Beuvink, I., Boulay, A., Fumagalli, S., Zilbermann, F., Ruetz, S., O’Reilly, T., Natt, F., Hall, J., Lane, H. A., & Thomas, G. (2005) · Cell · doi:10.1016/j.cell.2004.12.040 · Cited by 486
Gangloff, Y.-G., Mueller, M., Dann, S. G., Svoboda, P., Sticker, M., Spetz, J.-F., Um, S. H., Brown, E. J., Cereghini, S., Thomas, G., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9508-9516.2004 · Cited by 485 · cited 1×
“In addition, mTOR knockout mice are embryonic lethal as early as E5 and have defects in embryonic stem cell growth (Gangloff et al., 2004; Murakami et al., 2004), implying the mTOR plays a central role in primordial development.”
BackgroundRAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex.
Chiu, M. I., Katz, H., & Berlin, V (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12574 · Cited by 481
Manning, B. D. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200408161 · Cited by 476
Ellisen, L. W., Ramsayer, K. D., Johannessen, C. M., Yang, A., Beppu, H., Minda, K., Oliner, J. D., McKeon, F., & Haber, D. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00706-2 · Cited by 474
Arsham, A. M., Howell, J. J., & Simon, M. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212770200 · Cited by 463 · cited 1×
“…of AMPK activation and the energy status of the cell and is dominant to activators of mTOR such as insulin, amino acids, phorbol esters and serum (Arsham et al., 2003); but it is dependent on an intact TSC1/2 complex, as hypoxic treatment of TSC1 or TSC2 null mouse embryonic fibroblasts (MEFs)…”
BackgroundRapamycin Attenuates Load-Induced Cardiac Hypertrophy in Mice
Shioi, T., McMullen, J. R., Tarnavski, O., Converso, K., Sherwood, M. C., Manning, W. J., & Izumo, S. (2003) · Circulation · doi:10.1161/01.cir.0000057979.36322.88 · Cited by 462
TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth
Gao, X., & Pan, D. (2001) · Genes & Development · doi:10.1101/gad.901101 · Cited by 455
eIF4E – from translation to transformation
Mamane, Y., Petroulakis, E., Rong, L., Yoshida, K., Ler, L. W., & Sonenberg, N. (2004) · Oncogene · doi:10.1038/sj.onc.1207549 · Cited by 449
Regulation of mTOR and Cell Growth in Response to Energy Stress by REDD1
Sofer, A., Lei, K., Johannessen, C. M., & Ellisen, L. W. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.14.5834-5845.2005 · Cited by 449
Tuberin Regulates p70 S6 Kinase Activation and Ribosomal Protein S6 Phosphorylation
Goncharova, E. A., Goncharov, D. A., Eszterhas, A., Hunter, D. S., Glassberg, M. K., Yeung, R. S., Walker, C. L., Noonan, D., Kwiatkowski, D. J., Chou, M. M., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202678200 · Cited by 425
Rajasekhar, V. K., Viale, A., Socci, N. D., Wiedmann, M., Hu, X., & Holland, E. C. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00395-2 · Cited by 420
Haruta, T. (2000) · Molecular Endocrinology · doi:10.1210/me.14.6.783 · Cited by 419
Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus
Wang, X., Huong, S.-M., Chiu, M. L., Raab-Traub, N., & Huang, E.-S. (2003) · Nature · doi:10.1038/nature01818 · Cited by 416
Complex cellular responses to reactive oxygen species
Temple, M. D., Perrone, G. G., & Dawes, I. W. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.04.003 · Cited by 398 · cited 1×
“Complicating matters further, the effect of oxidizing agents seems to vary with the cell type tested, the dose and type of the oxidizing agent and the time of treatment (Boonstra and Post, 2004; Temple et al., 2005).”
BackgroundActivation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD
Baas, A. F. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg292 · Cited by 385
The role of c-myc in cellular growth control
Schmidt, E. V. (1999) · Oncogene · doi:10.1038/sj.onc.1202751 · Cited by 380
Kimura, N., Tokunaga, C., Dalal, S., Richardson, C., Yoshino, K., Hara, K., Kemp, B. E., Witters, L. A., Mimura, O., & Yonezawa, K. (2003) · Genes to Cells · doi:10.1046/j.1365-2443.2003.00615.x · Cited by 372
Smith, E. M., Finn, S. G., Tee, A. R., Browne, G. J., & Proud, C. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414499200 · Cited by 355
Rheb Binding to Mammalian Target of Rapamycin (mTOR) Is Regulated by Amino Acid Sufficiency
Long, X., Ortiz-Vega, S., Lin, Y., & Avruch, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500169200 · Cited by 349
Akt-regulated pathways in prostate cancer
Majumder, P. K., & Sellers, W. R. (2005) · Oncogene · doi:10.1038/sj.onc.1209096 · Cited by 344
Mahfouz, M. M., Kim, S., Delauney, A. J., & Verma, D. P. S. (2006) · The Plant Cell · doi:10.1105/tpc.105.035931 · Cited by 337
FAT: a novel domain in PIK-related kinases
Bosotti, R., Isacchi, A., & Sonnhammer, E. L. L. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01563-2 · Cited by 313
Reiling, J. H., & Hafen, E. (2004) · Genes & Development · doi:10.1101/gad.322704 · Cited by 293
Post-transcriptional control of gene expression: a genome-wide perspective
Mata, J., Marguerat, S., & Bähler, J. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.07.005 · Cited by 288
The ATRs, ATMs, and TORs Are Giant HEAT Repeat Proteins
Perry, J., & Kleckner, N. (2003) · Cell · doi:10.1016/s0092-8674(03)00033-3 · Cited by 268
Target of rapamycin-mediated amino acid signaling in mosquito anautogeny
Hansen, I. A., Attardo, G. M., Park, J.-H., Peng, Q., & Raikhel, A. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403460101 · Cited by 265
Selective and reversible inhibition of initiation of protein synthesis in mammalian cells
Saborio, J. L., Pong, S.-S., & Koch, G. (1974) · Journal of Molecular Biology · doi:10.1016/0022-2836(74)90360-x · Cited by 255
Redox regulation of the nutrient-sensitive raptor-mTOR pathway and complex
Sarbassov, D. D., & Sabatini, D. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506096200 · Cited by 248 · cited 1×
“Thiol oxidation also induces destabilization of the Raptor-mTOR interaction (Sarbassov and Sabatini, 2005), consistent with previous data that showed the Raptor-mTOR interaction is stabilized by mTOR inhibiting agents (Kim et al., 2002).”
ResultDesai, B. N., Myers, B. R., & Schreiber, S. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261702698 · Cited by 248
Biochemical and Functional Characterizations of Small GTPase Rheb and TSC2 GAP Activity
Li, Y., Inoki, K., & Guan, K.-L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.18.7965-7975.2004 · Cited by 240
Self-citationCorradetti, M. N., Inoki, K., & Guan, K.-L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c400557200 · Cited by 237 · cited 1×
“Subsequently, the human orthologues of Scylla and Charybdis, RTP801 and RTP801L, were shown to negatively regulate mTOR downstream of Akt and upstream of the TSC1/2 complex (Figure 2) (Brugarolas et al., 2004; Corradetti et al., 2005).”
BackgroundSelf-citationFeedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2
Manning, B. D., Logsdon, M. N., Lipovsky, A. I., Abbott, D., Kwiatkowski, D. J., & Cantley, L. C. (2005) · Genes & Development · doi:10.1101/gad.1314605 · Cited by 235
Johnson, R. A., Wang, X., Ma, X.-L., Huong, S.-M., & Huang, E.-S. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.6022-6032.2001 · Cited by 228
Stolovich, M., Tang, H., Hornstein, E., Levy, G., Cohen, R., Bae, S. S., Birnbaum, M. J., & Meyuhas, O. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.23.8101-8113.2002 · Cited by 228
Tee, A. R., Anjum, R., & Blenis, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303257200 · Cited by 217
Johnson, L., Shen, A., Boyle, L., Kunich, J., Pandey, K., Lemmon, M., Hermiston, T., Giedlin, M., McCormick, F., & Fattaey, A. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00060-0 · Cited by 191
Integration of Growth Factor and Nutrient Signaling
Shamji, A. F., Nghiem, P., & Schreiber, S. L. (2003) · Molecular Cell · doi:10.1016/j.molcel.2003.08.016 · Cited by 186
PDK2: the missing piece in the receptor tyrosine kinase signaling pathway puzzle
Dong, L., & Liu, F. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00011.2005 · Cited by 173
Patel, J., McLeod, L. E., Vries, R. G. J., Flynn, A., Wang, X., & Proud, C. G. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02992.x · Cited by 171
Hydrogen Peroxide Activates p70S6k Signaling Pathway
Bae, G., Seo, D. W., Kwon, H.-K., Lee, H. Y., Hong, S., Lee, Z., Ha, K., Lee, H. W., & Han, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.32596 · Cited by 165
Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV‐1 envelope
Castedo, M., Roumier, T., Blanco, J., Ferri, K. F., Barretina, J., Tintignac, L. A. J., Andréau, K., Perfettini, J., Amendola, A., Nardacci, R., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf391 · Cited by 165
Krause, U., Bertrand, L., & Hue, L. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03074.x · Cited by 163
Kudchodkar, S. B., Yu, Y., Maguire, T. G., & Alwine, J. C. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.11030-11039.2004 · Cited by 158
Iijima, Y., Laser, M., Shiraishi, H., Willey, C., Sundaravadivel, B., Xu, L., McDermott, P., & Kuppuswamy, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200328200 · Cited by 155
Wang, Z., Malone, M. H., Thomenius, M. J., Zhong, F., Xu, F., & Distelhorst, C. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303723200 · Cited by 144
DNA-damaging agents cause inactivation of translational regulators linked to mTOR signalling
Tee, A. R., & Proud, C. G. (2000) · Oncogene · doi:10.1038/sj.onc.1203622 · Cited by 135
Dames, S. A., Mulet, J. M., Rathgeb–Szabo, K., Hall, M. N., & Grzesiek, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501116200 · Cited by 134
Adenoviral proteins mimic nutrient/growth signals to activate the mTOR pathway for viral replication
O’Shea, C. C., Klupsch, K., Choi, S., Bagus, B., Soria, C. T., Shen, J., McCormick, F. P., & Stokoe, D. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600597 · Cited by 131
Ma, L., Teruya‐Feldstein, J., Behrendt, N., Chen, Z., Noda, T., Hino, O., Cordon‐Cardo, C., & Pandolfi, P. P. (2005) · Genes & Development · doi:10.1101/gad.1314405 · Cited by 121
The multifaceted role of mTOR in cellular stress responses
Proud, C. G. (2004) · DNA repair · doi:10.1016/j.dnarep.2004.03.012 · Cited by 103
Postgenomic global analysis of translational control induced by oncogenic signaling
Rajasekhar, V. K., & Holland, E. C. (2004) · Oncogene · doi:10.1038/sj.onc.1207546 · Cited by 102
Recent advances in the regulation of the TOR pathway by insulin and nutrients
Avruch, J., Lin, Y., Long, X., Murthy, S., & Ortiz-Vega, S. (2004) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200501000-00010 · Cited by 101
Gan, B., Melkoumian, Z. K., Wu, X., Guan, K., & Guan, J. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200411106 · Cited by 97
Self-citationFrese, K. K., Lee, S. S., Thomas, D. L., Latorre, I. J., Weiss, R. S., Glaunsinger, B. A., & Javier, R. T. (2003) · Oncogene · doi:10.1038/sj.onc.1206151 · Cited by 97
Horton, L. E., Bushell, M., Baus, D., Tilleray, V. J., Clemens, M. J., & Hensold, J. O. (2002) · Oncogene · doi:10.1038/sj.onc.1205662 · Cited by 94
Urano, J., Comiso, M. J., Guo, L., Aspuria, P.-J. P., Deniskin, R., Tabancay, A. P., Kato‐Stankiewicz, J., & Tamanoi, F. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04877.x · Cited by 93
Astrinidis, A., Senapedis, W. T., & Henske, E. P. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi444 · Cited by 93
Osmotic Stress Inhibits p70/85 S6 Kinase through Activation of a Protein Phosphatase
Parrott, L. A., & Templeton, D. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24731 · Cited by 83
Lin, L., Stringfield, T. M., Shi, X., & Chen, Y. (2005) · Biochemical Journal · doi:10.1042/bj20050553 · Cited by 78
Negative Regulation of TSC1-TSC2 by Mammalian D-Type Cyclins
Zacharek, S. J., Xiong, Y., & Shumway, S. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2236 · Cited by 72 · cited 1×
“…molecules critical for cell cycle progression have recently been shown to interact with TSC1 or TSC2 in mammalian cells, including: D-type cyclins (Zacharek et al., 2005), polo-like kinase 1 (Astrinidis et al., 2006) and the cyclin-dependent kinase inhibitor p27 (Rosner and Hengstschlager, 2004),…”
BackgroundFinlay, G. A., York, B., Karas, R. H., Fanburg, B. L., Zhang, H., Kwiatkowski, D. J., & Noonan, D. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401912200 · Cited by 66
Tuberin Binds p27 and Negatively Regulates Its Interaction with the SCF Component Skp2
Rosner, M., & Hengstschläger, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405528200 · Cited by 64
RAD001 (Everolimus) Improves the Efficacy of Replicating Adenoviruses that Target Colon Cancer
Homicskó, K., Lukashev, A. N., & Iggo, R. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0309 · Cited by 64
Naegele, S., & Morley, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404945200 · Cited by 63
Adenovirus Overrides Cellular Checkpoints for Protein Translation
O’Shea, C. C., Choi, S., McCormick, F. P., & Stokoe, D. (2005) · Cell Cycle · doi:10.4161/cc.4.7.1791 · Cited by 57
Kruppa, J., & Clemens, M. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb01767.x · Cited by 51
Constantinou, C., & Clemens, M. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208648 · Cited by 46
An essential role for protein synthesis in oncogenic cellular transformation
Bader, A. G., & Vogt, P. K. (2004) · Oncogene · doi:10.1038/sj.onc.1207550 · Cited by 43
Plant Growth and the TOR Pathway
Menand, B., Meyer, C., & Robaglia, C. (2004) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-18930-2_7 · Cited by 42
Proteins interacting with the tuberous sclerosis gene products
Rosner, M., Freilinger, A., & Hengstschl�ger, M. (2004) · Amino Acids · doi:10.1007/s00726-004-0119-z · Cited by 39
Tuberous Sclerosis Complex 2 Gene Product Interacts with Human SMAD Proteins
Birchenall-Roberts, M. C., Fu, T., Bang, O., Dambach, M., Resau, J. H., Petrow‐Sadowski, C., Bertolette, D. C., Lee, H.-J., Kim, S., & Ruscetti, F. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402790200 · Cited by 32
Hydrogen peroxide mediates arsenite activation of p70s6k and extracellular signal-regulated kinase
Jung, D. K., Bae, G., Kim, Y. K., Han, S.-H., Choi, W. S., Kang, H., Seo, D. W., Lee, H. Y., Cho, E., Lee, H. W., et al. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00320-3 · Cited by 29
Finlay, G. A., Thannickal, V. J., Fanburg, B. L., & Kwiatkowski, D. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1394 · Cited by 25
Cited by
p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling
Budanov, A. V., & Karin, M. (2008) · Cell · doi:10.1016/j.cell.2008.06.028 · Cited by 1,326
Life and death partners: apoptosis, autophagy and the cross-talk between them
Eisenberg-Lerner, A., Bialik, S., Simon, H.-U., & Kimchi, A. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.33 · Cited by 1,183
Wu, Y.-T., Tan, H.-L., Shui, G., Bauvy, C., Huang, Q., Wenk, M. R., Ong, C.-N., Codogno, P., & Shen, H.-M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.080796 · Cited by 1,127
Meloche, S., & Pouysségur, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210414 · Cited by 1,091
Heras-Sandoval, D., Pérez-Rojas, J. M., Hernández-Damián, J., & Pedraza-Chaverri, J. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.08.019 · Cited by 1,091
Metadata
- Authors
- Corradetti, M. N., & Guan, K.-L.
- Venue
- Oncogene
- Published
- 2006-10-16
- Volume
- 25
- Issue
- 48
- Pages
- 6347-6360
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2010538519
- Cited by
- 386
- References
- 142
- FWCI
- 12.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.